Evalueserve

DECEMBER 6, 2021

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. These companies will be able to reshape the competitive landscape of the pharmaceutical industry.

Capital 98

Capital Globalization Biotech Marketing 98

Alpha Sense BI

APRIL 12, 2024

That expert call may be one of the single advantages in the stack. Because your competitors likely have access to the same sources, this doesn’t provide a competitive advantage. In other words, what areas in your research topic can expert calls provide you with a competitive advantage?

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

MARCH 28, 2023

Third Bridges recognizes its shortcomings in its offerings—if you’re facing a unique business problem that has no pre-existing content offering potential solutions, you can take advantage of Third Bridge Forum or Connections. Third Bridge also recognizes that value chain information is typically fragmented, unqualified, and outdated.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52